• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19.按优先顺序接种疫苗对英国 COVID-19 死亡、住院和重症监护入院人数的影响。
Anaesthesia. 2021 May;76(5):608-616. doi: 10.1111/anae.15442. Epub 2021 Feb 11.
2
Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths.智利新冠肺炎疫苗接种的直接影响:避免发病、住院、入住 ICU 和死亡。
BMC Infect Dis. 2024 May 3;24(1):467. doi: 10.1186/s12879-024-09304-1.
3
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
4
Who should be prioritized for COVID-19 vaccination in China? A descriptive study.在中国,谁应该优先接种 COVID-19 疫苗?一项描述性研究。
BMC Med. 2021 Feb 10;19(1):45. doi: 10.1186/s12916-021-01923-8.
5
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.2019冠状病毒病的疫苗接种与非药物干预措施:一项数学建模研究
Lancet Infect Dis. 2021 Jun;21(6):793-802. doi: 10.1016/S1473-3099(21)00143-2. Epub 2021 Mar 18.
6
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.估计美国 COVID-19 疫苗接种计划对 65 岁及以上成年人 COVID-19 病例、急诊就诊、住院和死亡的早期影响:国家监测数据的生态分析。
Lancet. 2022 Jan 8;399(10320):152-160. doi: 10.1016/S0140-6736(21)02226-1. Epub 2021 Nov 3.
7
Comparing Critical Care Admissions Among Urban Populations Before and During the COVID-19 Pandemic.比较 COVID-19 大流行前后城市人口的重症监护病房入院情况。
Health Secur. 2021 Jun;19(S1):S34-S40. doi: 10.1089/hs.2021.0049. Epub 2021 Apr 30.
8
The effectiveness of COVID-19 vaccination in preventing hospitalisation and mortality: A nationwide cross-sectional study in Iran.COVID-19 疫苗接种在预防住院和死亡方面的有效性:伊朗全国性的横断面研究。
J Glob Health. 2024 Sep 27;14:05026. doi: 10.7189/jogh.14.05026.
9
Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.使用 SEIR 模型方法评估 COVID-19 不同年龄的疫苗接种优先级和针对特定年龄的疫苗接种策略。
PLoS One. 2021 Dec 22;16(12):e0261236. doi: 10.1371/journal.pone.0261236. eCollection 2021.
10
The Impact of the COVID-19 Pandemic on the Uptake of Influenza Vaccine: UK-Wide Observational Study.COVID-19 大流行对流感疫苗接种率的影响:英国范围的观察性研究。
JMIR Public Health Surveill. 2021 Apr 14;7(4):e26734. doi: 10.2196/26734.

引用本文的文献

1
Immunization against covid-19 and mortality in hospitalized patients: a retrospective cohort.Covid-19 免疫接种与住院患者死亡率:一项回顾性队列研究。
Rev Saude Publica. 2024 Mar 11;58:07. doi: 10.11606/s1518-8787.2024058005476. eCollection 2024.
2
Impact of vaccination status on clinical outcomes of hospitalized COVID-19 patients.疫苗接种状况对住院 COVID-19 患者临床结局的影响。
BMC Infect Dis. 2024 Feb 23;24(1):254. doi: 10.1186/s12879-024-09139-w.
3
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.预测 SARS-CoV-2 导致的健康结果的模型,包括疫苗接种的效果:系统评价。
Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1.
4
Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study.英格兰 COVID-19 成年患者的医疗资源利用情况以及住院和初级保健的费用:一项基于人群的队列研究。
BMJ Open. 2023 Dec 28;13(12):e075495. doi: 10.1136/bmjopen-2023-075495.
5
Vaccine effectiveness of COVID-19 and rebound in the real world.新冠病毒疫苗有效性和真实世界反弹的研究
Clin Exp Med. 2023 Dec;23(8):4975-4983. doi: 10.1007/s10238-023-01204-z. Epub 2023 Nov 16.
6
Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness.快速药物审批方法:大流行防范的研究视角。
Int J Environ Res Public Health. 2023 Jan 29;20(3):2404. doi: 10.3390/ijerph20032404.
7
Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers.BNT162b2 mRNA 新冠疫苗在西班牙医护人员中的有效性。
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan;41(1):33-35. doi: 10.1016/j.eimce.2022.11.010.
8
Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022.与不愿接种 COVID-19 疫苗相关的因素:2022 年伊朗设拉子的横断面研究。
PLoS One. 2022 Dec 12;17(12):e0278967. doi: 10.1371/journal.pone.0278967. eCollection 2022.
9
Inoculation works and health advocacy backfires: Building resistance to COVID-19 vaccine misinformation in a low political trust context.接种工作与健康宣传适得其反:在政治信任度较低的背景下增强对新冠疫苗错误信息的抵抗力
Front Psychol. 2022 Oct 25;13:976091. doi: 10.3389/fpsyg.2022.976091. eCollection 2022.
10
Distributed lag inspired machine learning for predicting vaccine-induced changes in COVID-19 hospitalization and intensive care unit admission.基于分布滞后模型的机器学习预测 COVID-19 住院和 ICU 入院人数的疫苗接种变化。
Sci Rep. 2022 Nov 5;12(1):18748. doi: 10.1038/s41598-022-21969-9.

本文引用的文献

1
COVID-19 vaccines: one step towards the beginning of the end of the global impact of the pandemic.新冠疫苗:迈向终结大流行全球影响开端的一步。
Anaesthesia. 2021 Apr;76(4):435-443. doi: 10.1111/anae.15365. Epub 2020 Dec 14.
2
Occupational COVID-19 risk for anaesthesia and intensive care staff - low-risk specialties in a high-risk setting.麻醉和重症监护人员的职业性新冠病毒风险——高风险环境中的低风险专业
Anaesthesia. 2021 Mar;76(3):295-300. doi: 10.1111/anae.15358. Epub 2020 Dec 11.
3
Oxford-AstraZeneca COVID-19 vaccine efficacy.牛津大学-阿斯利康新冠疫苗的效力
Lancet. 2021 Jan 9;397(10269):72-74. doi: 10.1016/S0140-6736(20)32623-4. Epub 2020 Dec 8.
4
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗(阿斯利康)对 SARS-CoV-2 的安全性和有效性:巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study.医护人员及其家庭成员因 2019 冠状病毒病住院的风险:全国关联队列研究。
BMJ. 2020 Oct 28;371:m3582. doi: 10.1136/bmj.m3582.
7
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.成人因冠状病毒 19 住院和死亡风险的生存风险预测算法(QCOVID):全国推导和验证队列研究。
BMJ. 2020 Oct 20;371:m3731. doi: 10.1136/bmj.m3731.
8
Use of "normal" risk to improve understanding of dangers of covid-19.使用“正常”风险来增进对新冠病毒19危险的理解。
BMJ. 2020 Sep 9;370:m3259. doi: 10.1136/bmj.m3259.
9
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
10
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征:前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.

按优先顺序接种疫苗对英国 COVID-19 死亡、住院和重症监护入院人数的影响。

Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19.

机构信息

Department of Anaesthesia and Intensive Care Medicine, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.

School of Medicine, University of Bristol, Bristol, UK.

出版信息

Anaesthesia. 2021 May;76(5):608-616. doi: 10.1111/anae.15442. Epub 2021 Feb 11.

DOI:10.1111/anae.15442
PMID:33572007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8013188/
Abstract

National (and global) vaccination provides an opportunity to control the COVID-19 pandemic, which disease suppression by societal lockdown and individual behavioural changes will not. We modelled how vaccination through the UK's vaccine priority groups impacts deaths, hospital and ICU admissions from COVID-19. We used the UK COVID-19 vaccines delivery plan and publicly available data to estimate UK population by age group and vaccination priority group, including frontline health and social care workers and individuals deemed 'extreme clinical vulnerable' or 'high risk'. Using published data on numbers and distributions of COVID-19-related hospital and ICU admissions and deaths, we modelled the impact of vaccination by age group. We then modified the model to account for hospital and ICU admission, and death among health and social care workers and the population with extreme clinical vulnerability and high risk. Our model closely matches the government's estimates for mortality after vaccination of priority groups 1-4 and groups 1-9. The model shows vaccination will have a much slower impact on hospital and ICU admissions than on deaths. The early prioritisation of healthcare staff and clinically vulnerable patients increases the impact of vaccination on admissions and also protects the healthcare service. An inflection point, when 50% of the adult population has been vaccinated - with deaths reduced by 95% and hospital admissions by 80% - may be a useful point for re-evaluating vaccine prioritisation. Our model suggests substantial reductions in hospital and ICU admissions will not occur until late March and into April 2021.

摘要

全国(和全球)接种疫苗为控制 COVID-19 大流行提供了机会,而通过社会封锁和个人行为改变来抑制疾病则无法实现这一目标。我们模拟了通过英国疫苗优先群体接种疫苗如何影响 COVID-19 的死亡、住院和 ICU 入院人数。我们使用了英国 COVID-19 疫苗接种计划和公开数据来估计按年龄组和疫苗优先组划分的英国人口,包括一线卫生和社会保健工作者以及被认为“极度临床脆弱”或“高风险”的个人。使用有关 COVID-19 相关住院和 ICU 入院和死亡人数和分布的已发表数据,我们按年龄组模拟了疫苗接种的影响。然后,我们修改了模型,以考虑卫生和社会保健工作者以及具有极度临床脆弱性和高风险的人群中的住院和 ICU 入院以及死亡人数。我们的模型与政府对优先组 1-4 和组 1-9 接种疫苗后的死亡率的估计非常吻合。该模型表明,与死亡相比,疫苗接种对住院和 ICU 入院的影响要慢得多。优先考虑医护人员和临床脆弱患者可提高疫苗接种对入院的影响,并保护医疗服务。当 50%的成年人口接种疫苗时(死亡减少 95%,住院减少 80%),可能是重新评估疫苗接种优先级的一个有用的转折点。我们的模型表明,到 2021 年 3 月下旬和 4 月,住院和 ICU 入院人数才会大幅减少。